Pharma Marketing Network

Is this a gamble for Pfizer or it's only option to protect the market for Celebrex?

Recognizing Excellence in Social Media Marketing Leadership: Instead of recognizing specific pharma social media sites or campaigns, why not give kudos to the pioneers within the pharma industry who have lead the way?

By combining better Internet search tools, the vast resources of the Web and online personal health records, both Google and Microsoft are betting they can enable people to make smarter choices about their health habits and medical care. But data within PHRs also can be used to target advertising to specific segments of people.

This survey solicits your opinion possible FDA future decisions regarding off-label drug promotion to patient and consumer audiences.

Who's Better for Pharma: Obama or McCain? Click here for a summary of survey results (interactive online version). ...

Please take a few minutes to tell us who you think President-elect Obama should nominate as the new FDA Commissioner after he is sworn in as president. We've assembled a list of 10 contenders that have been suggested in blogs and other news sources.

You must get out there and network if you expect to keep your job, keep your current clients, find new new clients, and generally CREATE opportunities rather than wait for them to come to you! That is why Pharma Marketing Network is AGAIN hosting a networking event for pharmaceutical marketing professionals.

What impact will issues like drug reimporation, weak pipelines, decreasing profits, drug recalls, class action lawsuits, government regulation, etc., have on the course of the pharmaceutical industry in 2005?

Shouldn't we make sure that when it comes time for the FDA to actually create a guidance document on social media that it does it with input from ALL stakeholders?

This survey address issues relate dto 'Ethnic Drugs' and 'Genetic Marketing'